Spatially fractionated radiation therapy for treating recurrent glioblastoma: a dosimetric feasibility study
In summary, our planning study demonstrates that dosimetrically acceptable SFRT plans can be achieved for recurrent GBM. The main clinical consideration is balancing the potential benefit of SFRT against the risk of radiation-induced necrosis.
Authors
- Jihyung Yoon (ORCID: https://orcid.org/0000-0001-8588-3380)
- Matthew J. Webster (ORCID: https://orcid.org/0009-0008-4306-5441)
- Alexander R. Podgorsak (ORCID: https://orcid.org/0000-0001-6351-703X)
- Brian Marples (ORCID: https://orcid.org/0000-0002-8684-4372)
- Sean Tanny (ORCID: https://orcid.org/0000-0002-0915-9187)
- Michael T. Milano (ORCID: https://orcid.org/0000-0001-8676-2855)
- Hyunuk Jung
- Yuwei Zhou (ORCID: https://orcid.org/0000-0001-9582-7331)
- Michael Hazoglou
- Wesley Rivais
- Dandan Zheng
- Fiona Li
Institutions
- University of Rochester Medical Center (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fonc.2025.1691132
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00